BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 18019783)

  • 21. Accomplish more blood pressure lowering with initial fixed-dose combination therapy.
    Cardiovasc J Afr; 2009; 20(2):153. PubMed ID: 19421660
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?].
    Dechend R; Derer W; Müller DN
    MMW Fortschr Med; 2009 Nov; 151(45):46-7. PubMed ID: 19960726
    [No Abstract]   [Full Text] [Related]  

  • 23. Public health value of fixed-dose combinations in hypertension.
    Ruilope LM; Burnier M; Muszbek N; Brown RE; Keskinaslan A; Ferber P; Harms G
    Blood Press Suppl; 2008 Jun; 1():5-14. PubMed ID: 18705530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management of patients with hypertension resistant to treatment].
    Girerd X; Hanon O
    Rev Prat; 1999 Mar; 49(5):527-31. PubMed ID: 10358403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of an additive antihypertensive effect of prazosin and polythiazide in out-patient.
    Kuokkanen K; Mattila MJ
    Curr Ther Res Clin Exp; 1975 May; 17(5):431-6. PubMed ID: 805026
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fixed drug combinations--the pros and the cons].
    Rustenbeck I
    Med Monatsschr Pharm; 2009 Apr; 32(4):141-6. PubMed ID: 19445271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Initial combination treatment of hypertension].
    Düsing R
    MMW Fortschr Med; 2004 Nov; 146(47):46-8. PubMed ID: 15624658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Basic principles and possible variations in combination antihypertensive therapy].
    Scholze J
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):155-63. PubMed ID: 9244658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed-drug combinations as first-line treatment for hypertension.
    Rosenthal T; Gavras I
    Prog Cardiovasc Dis; 2006; 48(6):416-25. PubMed ID: 16714161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.
    Waeber B; Mourad JJ
    Am J Hypertens; 2006 Sep; 19(9):985-6. PubMed ID: 16942945
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-responders.
    Os I
    Wien Med Wochenschr; 1995; 145(15-16):357-60. PubMed ID: 7502515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antihypertensive therapy with fixed combinations].
    Holzgreve H
    Internist (Berl); 1996 Aug; 37(8):852-6. PubMed ID: 8964679
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term drug therapy of arterial hypertension including patient compliance].
    Linss G; Kiesewetter R
    Z Arztl Fortbild (Jena); 1984; 78(24):1047-53. PubMed ID: 6442069
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fixed antihypertensive drug combinations].
    Waeber B
    Ther Umsch; 1999 Jan; 56(1):33-6. PubMed ID: 10067132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Out-of-pocket and total costs of fixed-dose combination antihypertensives and their components.
    Rabbani A; Alexander GC
    Am J Hypertens; 2008 May; 21(5):509-13. PubMed ID: 18437141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of recent fixed-dose combination therapies in the management of hypertension.
    Khanna A; Lefkowitz L; White WB
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):477-83. PubMed ID: 18695388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy: advantages and disadvantages of first-line fixed dose therapy.
    Hall WD
    Ethn Dis; 1997; 7(2):169-71. PubMed ID: 9386957
    [No Abstract]   [Full Text] [Related]  

  • 40. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI
    Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.